| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.29 | 2e-07 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-06 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.23 | 0.0002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |